Advanced glycation end products in myocardial reperfusion injury.

about

Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells Pyridoxamine improves survival and limits cardiac dysfunction after MI.

P2860

Q33582330-B7F9AF52-ADEC-4209-95E3-F4302F4350F6 Q47426086-767BFC35-38B6-4034-A859-11F4D645D64F

P2860

Advanced glycation end products in myocardial reperfusion injury.

Item

http://www.wikidata.org/entity/Q51373390

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Advanced glycation end products in myocardial reperfusion injury.

@en

Advanced glycation end products in myocardial reperfusion injury.

@nl

type

Item

label

Advanced glycation end products in myocardial reperfusion injury.

@en

Advanced glycation end products in myocardial reperfusion injury.

@nl

prefLabel

Advanced glycation end products in myocardial reperfusion injury.

@en

Advanced glycation end products in myocardial reperfusion injury.

@nl

P1476

Advanced glycation end products in myocardial reperfusion injury

@en

P2093

Ivan Pecháň

http://www.w3.org/2001/XMLSchema#string

Johana Holzerová

http://www.w3.org/2001/XMLSchema#string

Ján Murín

http://www.w3.org/2001/XMLSchema#string

Lukáč Halčák

http://www.w3.org/2001/XMLSchema#string

Martin Braun

http://www.w3.org/2001/XMLSchema#string

Matúš Kúdela

http://www.w3.org/2001/XMLSchema#string

Peter Jáni

http://www.w3.org/2001/XMLSchema#string

Vojtech Parrák

http://www.w3.org/2001/XMLSchema#string

P2860

Biochemistry and molecular cell biology of diabetic complications

The pathobiology of diabetic complications: a unifying mechanism

Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy.

Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine

Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells.

Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients.

Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation.

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.

Toxicity of the AGEs generated from the Maillard reaction: on the relationship of food-AGEs and biological-AGEs.

Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.

P2888

s00380-011-0147-z

P304

208-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00380-011-0147-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21562777

http://www.w3.org/2001/XMLSchema#string

P921

reperfusion injury

Advanced glycation end products in myocardial reperfusion injury.

about

P2860

P2860

Advanced glycation end products in myocardial reperfusion injury.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921